Diabetes and the kidney

Module 3: Treatment modalities

Please log in to access the chapters in this module.
CME Credits: 1
Module duration: 1 hour
Launch date: Winter 2019 (version 1)
Updated: Spring 2023 (version 2)
Expiry date: March 2027
Audience: Diabetes and Metabolism Specialists (Subspeciality), Endocrinologists (Subspeciality), General Physicians (Advanced), Nephrologists (Subspeciality)

My name is Sally Marshall. I’m Professor of Diabetes at the University of Newcastle and I am also the Editor-in-Chief of Diabetologia, the official journal of the European Association for the Study of Diabetes. Although diabetic kidney disease remains an extremely serious complication of diabetes, there is good news. Over the last few years, we have learned that it is possible to prevent the development of kidney disease in people with diabetes and, even if kidney disease does develop, that we can slow the rate of progression – and buy years free of dialysis – for individuals.

The risk of developing diabetic kidney disease (DKD) is particularly reduced by good blood glucose and blood pressure control. For those with DKD, the goal of management is to reduce the risk of renal disease progression, as well as the risk of cardiovascular morbidities. Even with intensive management in the setting of clinical trials, many people with diabetes still experience a progressive decline in renal function, and eventually, referral to a nephrologist may be appropriate. This module is designed to help you understand the current treatment options for DKD.

Learning Outcomes

By the end of this module, you will be able to:

Summarise the relationship between tight blood pressure and glycaemic control and renal function in people with type 1 or type 2 diabetes and diabetic kidney disease (DKD)

Evaluate the treatment options for people with type 1 or type 2 diabetes and DKD to support tight glycaemic and blood-pressure control, and achievement of glycaemic and blood-pressure targets

Plan multifactorial intervention strategies, including diet, lifestyle and pharmacological treatment, with a series of case studies of people with type 1 or type 2 diabetes and DKD


This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.


Contributors

Professor
Sally Marshall
Author
Professor
Per-Henrik Groop
Expert Reviewer
Assessment Setter
Assessment Setter
Professor
Peter Rossing
Assessment Setter